Sid Mukherjee's Vor adds clinical manufacturing facility at existing Boston-area site, beefing up for a commercial push
When Siddhartha Mukherjee founded Vor Biopharma in 2016, he had the goal of rewriting the book on stem cell transplants. To get there, Vor needed a leg up in clinical manufacturing — and now it has one.
Vor will build an in-house clinical manufacturing facility next to its Cambridge, MA headquarters, which is anticipated to be up and running in 2022, the company said Thursday. The outlay is all out of pocket, but Vor says the buildout won’t impact its cash runway, which is sufficient to early 2023.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 163,800+ biopharma pros reading Endpoints daily — and it's free.